Literature DB >> 28296796

Updates to the Spectrum/Estimations and Projections Package model for estimating trends and current values for key HIV indicators.

John Stover1, Tim Brown, Robert Puckett, Wiwat Peerapatanapokin.   

Abstract

BACKGROUND: The Spectrum model is used by national programs and UNAIDS to prepare annual estimates of the status of the HIV epidemic in 160 countries. The model and assumptions are updated regularly under the guidance of the UNAIDS Reference Group on Estimates, Modelling and Projections in response to new data, studies, and program needs. This study describes the most recent updates for the 2016 round of estimates.
METHODS: Meetings of the UNAIDS Reference Group include individuals with extensive knowledge of HIV programs, research, statistics, and public policy. The Reference Group also collaborates with other institutions (such as the United Nations Population Division and the US Census Bureau) and projects (such as the ALPHA Network and IeDEA Consortium) to ensure that latest methods and data are used in the preparation of the annual estimates. In the past year new methods and data have been introduced for pediatric estimates, incidence fitting, and ART mortality (described elsewhere in this supplement).
RESULTS: The 2016 version of Spectrum includes a number of other enhancements, including updated demographic data from the United Nations Population Division, program options for treatment (treat all), and programs to prevent mother-to-child transmission (option B+), improved methods to aggregate uncertainty to regional and global levels, several options for generating incidence trends, adjustments to the Estimations and Projections Package model to better incorporate aging effects, adjustments to account for the changing bias in prevalence from antenatal clinic surveillance, and an option to fit incidence among all adults 15+ in addition to 15-49.
CONCLUSION: The new methods and data implemented in the 2016 version of Spectrum allow national programs more flexibility in describing their programs and improve the estimates of key indicators and their uncertainty.

Entities:  

Mesh:

Year:  2017        PMID: 28296796     DOI: 10.1097/QAD.0000000000001322

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  33 in total

1.  Vascular cognitive impairment and HIV-associated neurocognitive disorder: a new paradigm.

Authors:  Lucette A Cysique; Bruce J Brew
Journal:  J Neurovirol       Date:  2019-01-11       Impact factor: 2.643

2.  Effect of HIV Infection and Antiretroviral Treatment on Pregnancy Rates in the Western Cape Province of South Africa.

Authors:  Leigh F Johnson; Themba Mutemaringa; Alexa Heekes; Andrew Boulle
Journal:  J Infect Dis       Date:  2020-06-11       Impact factor: 5.226

3.  Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.

Authors: 
Journal:  Lancet       Date:  2018-11-08       Impact factor: 79.321

4.  Low Case Finding Among Men and Poor Viral Load Suppression Among Adolescents Are Impeding Namibia's Ability to Achieve UNAIDS 90-90-90 Targets.

Authors:  Simon Agolory; Michael de Klerk; Andrew L Baughman; Souleymane Sawadogo; Nicholus Mutenda; Ndumbu Pentikainen; Naemi Shoopala; Adam Wolkon; Negussie Taffa; Gram Mutandi; Anna Jonas; Assegid Tassew Mengistu; Edington Dzinotyiweyi; Dimitri Prybylski; Ndapewa Hamunime; Amy Medley
Journal:  Open Forum Infect Dis       Date:  2018-08-11       Impact factor: 3.835

5.  Accounting for nonsampling error in estimates of HIV epidemic trends from antenatal clinic sentinel surveillance.

Authors:  Jeffrey W Eaton; Le Bao
Journal:  AIDS       Date:  2017-04       Impact factor: 4.177

6.  Modeling of the HIV epidemic and continuum of care in French Guiana.

Authors:  Mathieu Nacher; Leila Adriouch; Florence Huber; Vincent Vantilcke; Félix Djossou; Narcisse Elenga; Antoine Adenis; Pierre Couppié
Journal:  PLoS One       Date:  2018-05-24       Impact factor: 3.240

7.  Sociodemographic determinants of attrition in the HIV continuum of care in Brazil, in 2016.

Authors:  Ana Roberta Pati Pascom; Mariana Veloso Meireles; Adele Schwartz Benzaken
Journal:  Medicine (Baltimore)       Date:  2018-05       Impact factor: 1.889

8.  Integrated screening and treatment services for HIV, hypertension and diabetes in Kenya: assessing the epidemiological impact and cost-effectiveness from a national and regional perspective.

Authors:  Parastu Kasaie; Brian Weir; Melissa Schnure; Chen Dun; Jeff Pennington; Yu Teng; Richard Wamai; Kipkoech Mutai; David Dowdy; Chris Beyrer
Journal:  J Int AIDS Soc       Date:  2020-06       Impact factor: 5.396

9.  HIV-1 Recent Infection Testing Algorithm With Antiretroviral Drug Detection to Improve Accuracy of Incidence Estimates.

Authors:  Andrew C Voetsch; Yen T Duong; Paul Stupp; Suzue Saito; Stephen McCracken; Trudy Dobbs; Frieda S Winterhalter; Daniel B Williams; Assegid Mengistu; Owen Mugurungi; Prisca Chikwanda; Godfrey Musuka; Clement B Ndongmo; Sindisiwe Dlamini; Harriet Nuwagaba-Biribonwoha; Munyaradzi Pasipamire; Belete Tegbaru; Frehywot Eshetu; Samuel Biraro; Jennifer Ward; Dorothy Aibo; Andrew Kabala; George S Mgomella; Optatus Malewo; Jeremiah Mushi; Danielle Payne; Yohannes Mengistu; Fred Asiimwe; Judith D Shang; Emily K Dokubo; Laura T Eno; Anne-Cécile Zoung-Kanyi Bissek; Leonard Kingwara; Muthoni Junghae; John N Kiiru; Richard C N Mwesigwa; Shirish Balachandra; Roger Lobognon; Elizabeth Kampira; Mervi Detorio; Ernest L Yufenyuy; Kristin Brown; Hetal K Patel; Bharat S Parekh
Journal:  J Acquir Immune Defic Syndr       Date:  2021-08-01       Impact factor: 3.771

10.  Simulation Modeling and Metamodeling to Inform National and International HIV Policies for Children and Adolescents.

Authors:  Andrea Ciaranello; Annette H Sohn; Intira Jeannie Collins; Claire Rothery; Elaine J Abrams; Beth Woods; Pamela Pei; Martina Penazzato; Mary Mahy
Journal:  J Acquir Immune Defic Syndr       Date:  2018-08-15       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.